The Journal of Investigative Medicine (JIM) is the official publication of the American Federation for Medical Research (AFMR). Publishing high-quality original articles and reviews in the areas of basic, translational and clinical research, it covers the entire spectrum of biomedical investigation. Every month, Editor-in-Chief Richard W. McCallum will speak with fellow experts about the latest advances and developments in biomedical research. These podcasts will provide JIM's readers and AFMR members alike with insightful overviews of the subjects that define the field today. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.
Reflections on my presidency and the future of AFMR with Samrat Das, MD
Editor-in-Chief Dr. Richard McCallum and Associate Professor of Pediatrics and the Director of Pediatric Undergraduate Medical Education at Duke University School of Medicine, Dr. Samrat Das, discuss what it has been like to be the president of the American Federation of Medical Research (AFMR) over the last year. Join us as we honor Dr. Das during his final days as president of AFMR. Dr. Das discusses advice for future presidents and his own future career plans. We are very grateful for all the work Dr. Das has done for AFMR, and we wish him the very best in his future endeavors.
Irritable Bowel Syndrome
Editor-in-Chief Dr. Richard McCallum and Assistant Professor of Medicine at Mayo Clinic School of Medicine, Dr. Lucinda Harris, discuss stress and IBS, antibiotic treatment options, and new findings regarding IBS in females and military service members. Dr. Harris is also a consultant at the Division of Gastroenterology and Hepatology at Mayo Clinic Scottsdale and is a current member of the Gastroenterology Fellowship committee. Her special clinical and research interests include IBS, gastroparesis, chronic constipation, and pelvic floor disorders as well as celiac disease and autonomic disorders.
Colon Cancer Awareness
In honor of Colon Cancer Awareness Month, Editor-in-Chief Dr. Richard McCallum and Dr. Ihsan Al Bayati, Assistant Professor of Gastroenterology at TTUHSC Paul L. Foster School of Medicine, discuss different screening modalities for colon cancer, risk factors for colon cancer, Lynch syndrome, treatment, staging, and prognosis for colorectal cancer.
JIM Update by the Editor-in-Chief
Editor-in-Chief Dr. Richard McCallum shares the latest details about JIM’s progress during 2021. Additionally, Dr. McCallum discusses readers’ perspectives about the journal and what we can hope to see this upcoming year from JIM.
Thyroid Month: Review of Thyroid Disorders
In this episode of the JIM podcast, Editor-in-Chief Dr. Richard McCallum, speaks with Dr. Tamis Bright, the Chief of the Division of Endocrinology at Texas Tech El Paso. Last year on this podcast series, she discussed hypothyroidism. She now returns to discuss the effects, screening tools, and treatment modalities for hyperthyroidism.
Dr. Tamis Bright, MD, is a Clinical Endocrinologist and Associate Professor at Texas Tech Health Sciences Paul L. Foster School of Medicine in El Paso, Texas. Additionally, she is known as an Endocrinology, Diabetes, and Metabolism specialist. Dr. Bright has more experience with Thyroid Disorders than other specialists in her area. She is affiliated with University Medical Center of El Paso, where she treats a wide variety of patients. Dr. Bright received her medical degree from Loyola University Chicago Stritch School of Medicine and has been in practice for more than 20 years.
New Pharmacology for Weight Loss with Dr. Gurdeep Singh
In this episode of the JIM podcast, Editor-in-Chief Dr. Richard McCallum speaks with Dr. Gurdeep Singh, the first author of the review entitled “Wegovy(Semaglutide) a new weight loss drug for chronic weight management” which was Editor’s choice in the upcoming January issue of the Journal of Investigative Medicine.
Dr. Gurdeep Singh, MD, FACE a Clinical Endocrinologist from Lake Erie College of Osteopathic Medicine at Our Lady of Lourdes Memorial Hospital in Binghamton, New York.